The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 26, 2021

Filed:

Dec. 21, 2020
Applicant:

Pfizer Inc., New York, NY (US);

Inventors:

Tracy Chia-Chien Kuo, San Mateo, CA (US);

Javier Fernando Chaparro Riggers, San Mateo, CA (US);

Wei Chen, Cupertino, CA (US);

Amy Shaw-Ru Chen, San Jose, CA (US);

Edward Derrick Pascua, Oakland, CA (US);

Thomas John Van Blarcom, Oakland, CA (US);

Leila Marie Boustany, Redwood City, CA (US);

Weihsien Ho, Belmont, CA (US);

Yik Andy Yeung, South San Francisco, CA (US);

Pavel Strop, San Mateo, CA (US);

Arvind Rajpal, San Francisco, CA (US);

Assignee:

PFIZER INC., New York, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 39/395 (2006.01); A61K 31/454 (2006.01); A61K 31/704 (2006.01); A61K 31/69 (2006.01); A61K 47/68 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2878 (2013.01); A61K 31/454 (2013.01); A61K 31/69 (2013.01); A61K 31/704 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); A61K 47/6801 (2017.08); A61K 47/6849 (2017.08); C07K 16/2803 (2013.01); C07K 16/2809 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/31 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present invention relates to bispecific antibodies that specific bind to BCMA (B-Cell Maturation Antigen) and CD3 (Cluster of Differentiation 3). Method of making the bispecific antibodies and method of using the bispecific antibodies for the treatment of multiple myeloma are also provided.


Find Patent Forward Citations

Loading…